Wilson Disease: A Case Report of Psychosis Preceding Parkinsonism.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
16 Aug 2023
16 Aug 2023
Historique:
medline:
17
8
2023
pubmed:
16
8
2023
entrez:
16
8
2023
Statut:
epublish
Résumé
BACKGROUND A first psychotic episode requires the exclusion of toxic-metabolic, inflammatory, infective, and neoplastic causes. Wilson disease is a rare, autosomal recessive disorder of copper metabolism and can present with neuropsychiatric symptoms secondary to copper accumulation in the brain. CASE REPORT We describe the case of a 48-year-old man with parkinsonism on a background of longstanding schizophrenia and psychotic depression in the setting of previously undiagnosed Wilson disease. The common history of neuropsychiatric disturbance and neuroleptic use complicated the assessment of parkinsonism. However, close attention to the temporal appearance of symptoms and signs differentiated his case from drug-induced parkinsonism, which commonly develops hours to weeks after commencement or uptitration of antipsychotic medication. The early features of sialorrhea and dysarthria were also atypical for idiopathic Parkinson disease. The diagnosis was confirmed by serum copper testing and supported by Kayser-Fleischer rings on bedside ophthalmological examination. Magnetic resonance imaging (MRI) of the brain demonstrated copper accumulation in the basal ganglia and pons, contributing to the characteristic neurological manifestations of an akinetic-rigid syndrome with dysarthria. CONCLUSIONS Serum copper testing is easily obtained and should be considered as part of the first-line investigations for new neuropsychiatric disturbances. Although rare, Wilson disease, if diagnosed early, is a potentially treatable and reversible cause of psychosis. With advanced disease, extrapyramidal findings on examination correlate with MRI brain changes, aiding the clinical assessment in differentiating the disease from drug-induced parkinsonism.
Identifiants
pubmed: 37583127
pii: 940561
doi: 10.12659/AJCR.940561
pmc: PMC10441581
doi:
Substances chimiques
Copper
789U1901C5
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e940561Références
J Clin Neurol. 2012 Mar;8(1):15-21
pubmed: 22523509
Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):53-62
pubmed: 24120023
BMJ Case Rep. 2013 Aug 09;2013:
pubmed: 23933866
Lancet. 2007 Feb 3;369(9559):397-408
pubmed: 17276780
Neurol Ther. 2018 Dec;7(2):233-248
pubmed: 30027457
BMJ. 2007 Mar 31;334(7595):686-92
pubmed: 17395949
Mov Disord. 2010 Apr 30;25(6):672-8
pubmed: 20437536
AJNR Am J Neuroradiol. 2012 Mar;33(3):407-14
pubmed: 21920862
AJNR Am J Neuroradiol. 2019 Jan;40(1):178-183
pubmed: 30635331
P T. 2015 Aug;40(8):504-32
pubmed: 26236139
Gut. 2000 Mar;46(3):415-9
pubmed: 10673307
Ther Adv Psychopharmacol. 2018 Jul;8(7):199-211
pubmed: 29977520
Nat Rev Dis Primers. 2018 Sep 6;4(1):21
pubmed: 30190489